Insider trades
Robert E. Waltermire, Chief Officer of Madrigal Pharmaceuticals MDGL, has filed 0 purchases and 30 sales on the open market. The latest trade was on 25/03/05.
Robert E. Waltermire
Senior VP, Chief Pharma Dev
- First filing
- 23/01/18
- Trades
- 57 trades
- Buys / sales
- 0 / 30
- 12-month net buying
- No record
- Last trade
- 25/03/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MDGL | Open-market sale | 25/03/05 | 25/03/07 | 14,113 sh9 trades | $341.33avg. | $4,817,121.34 | −79.1% |
MDGL | Open-market sale | 25/02/28 | 25/03/04 | 1,227 sh2 trades | $341.07avg. | $418,492.73 | −24.8% |
| Open-market sale | 25/01/24 | 25/01/27 | 103 sh | $335.24 | $34,529.72 | −2.0% | |
| Open-market sale | 25/01/17 | 25/01/17 | 442 sh | $273.41 | $120,847.22 | −8.0% | |
| Open-market sale | 24/06/14 | 24/06/18 | 1,900 sh | $280.00 | $532,000 | −25.7% | |
| Open-market sale | 24/06/12 | 24/06/14 | 2,000 sh | $285.00 | $570,000 | −26.7% | |
| Open-market sale | 24/05/21 | 24/05/23 | 1,036 sh | $231.34 | $239,668.24 | −15.9% | |
MDGL | Open-market sale | 23/12/14–23/12/15 | 23/12/18 | 4,000 sh4 trades | $235.50avg. | $942,000 | −41.4% |
MDGL | Open-market sale | 23/12/12–23/12/13 | 23/12/14 | 3,800 sh4 trades | $222.82avg. | $846,700 | −40.1% |
MDGL | Open-market sale | 23/02/28–23/03/01 | 23/03/02 | 10,000 sh6 trades | $273.24avg. | $2,732,438.36 | −63.8% |